Patents by Inventor Anne Tybjaerg-Hansen

Anne Tybjaerg-Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF PROGNOSIS
    Publication number: 20150093765
    Abstract: The present invention relates to the use of soluble CD163 as a prognostic marker for the assessment of the risk for contracting a disorder, in particular for contracting diabetes and/or a liver disorder. The invention also relates to the use of CD163 as a prognostic marker for assessing lifetime expectancy.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 2, 2015
    Inventors: Søren Moestrup, Ruth Frikke-Schmidt, Anne Tybjaerg-Hansen, Holger J. Moller
  • METHOD OF PROGNOSIS
    Publication number: 20120252041
    Abstract: The present invention relates to the use of soluble CD163 as a prognostic marker for the assessment of the risk for contracting a disorder, in particular for contracting diabetes and/or a liver disorder. The invention also relates to the use of CD163 as a prognostic marker for assessing lifetime expectancy.
    Type: Application
    Filed: October 12, 2010
    Publication date: October 4, 2012
    Applicants: Region Midjylland, Aarhus Universitet
    Inventors: Søren Moestrup, Ruth Frikke-Schmidt, Anne Tybjaerg-Hansen, Holger J. Møller